Investors

Exits and Awards

We took two companies public and exited six companies.
Read more

IR Contact Details

Judith Kleinman
Director, Investor Relations and Corporate Communications
The Trendlines Group
+972.72.260.7000
judith@trendlines.com

 


Romil Singh / Reyna Mei
Financial PR Pte Ltd
+65 6438 2990
investors@trendlines.com

Board of Directors

D. Todd Dollinger

Todd Dollinger – Chairman and Chief Executive Officer

Todd Dollinger brings decades of entrepreneurial experience to Trendlines.

He serves as the Chairman of Trendlines Medical Singapore and as Investment Committee chair of Trendlines Incubators Israel. As well, Todd is a director and chairman of a number of Trendlines’ portfolio companies. He founded The Trendlines Group with Steve Rhodes in 2007 and shares the positions of Chairman and CEO of Trendlines with Steve. Together, they lead the Group’s strategy.

The Start of Trendlines

In 1991, Todd joined the marketing department of Israeli medical device start-up SRD Medical and went on to become SRD’s CEO. It was at SRD that Todd met Steve.

In 1993, Todd and Steve founded Trendlines International. Under their leadership, Trendlines International grew to become one of Israel’s leading business development consulting firms. They merged the principal consulting activities of Trendlines International into the Group in 2008.

Under the strength of their longstanding partnership, Todd and Steve oversaw the Singapore Stock Exchange IPO in 2015, took two companies public on the Tel Aviv Stock Exchange (E.T.View Medical and FlowSense Medical), and expanded the Group’s activities internationally, including raising funds for Trendlines’ portfolio companies around the world.

Steve Rhodes

Steve Rhodes – Chairman and Chief Executive Officer

Steve Rhodes brings decades of business, finance, and banking experience to his position at Trendlines.

He serves as the Chairman of Trendlines Incubators Israel and as Investment Committee Chair of Trendlines Medical Singapore. Steve is a director and chairman of a number of Trendlines’ portfolio companies. He founded The Trendlines Group with Todd Dollinger in 2007 and shares the positions of Chairman and CEO of Trendlines with Todd. Together, they lead the Group’s strategy.

The Start of Trendlines

In 1988, Steve joined SRD Medical. After serving as its CFO, he became its VP Sales and Marketing. It was at SRD that Steve met Todd. In 1993, Steve and Todd founded Trendlines International. Under their leadership, Trendlines International grew to become one of Israel’s leading business development consulting firms.

In 2004, Steve became CEO of the of the incubator that is now Trendlines Medical, a position he held until 2010.

Todd and Steve founded The Trendlines Group in 2007 and merged the principal consulting activities of Trendlines International into the Group the following year.

Under the strength of their longstanding partnership, Todd and Steve oversaw the Singapore Stock Exchange IPO in 2015, took two companies public on the Tel Aviv Stock Exchange (E.T.View Medical and FlowSense Medical), and expanded the Group’s activities internationally, including raising funds for Trendlines’ portfolio companies around the world.

Zeev Bronfeld – Non-Executive Director

Zeev Bronfeld is currently the CEO of Bio-Cell Ltd. and the CEO of M.B.R.T Development and Investment Ltd. Bronfeld has significant experience in the management and building medical device and biotechnology companies. He is a co-founder of Bio-Cell, an Israeli publicly traded holding company specializing in biotechnology companies, and served as its CEO and director (until 2014). He is a director and chairman of D.N.A. Biomedical Solutions, a publicly traded company (TASE). He also serves as a director of the AMEX-listed company, Protalix BioTherapeutics, Inc., and the NASDAQ-listed company, MacroCure Ltd. He serves as director and chairman of a number of private companies.

Elka Nir – Lead Independent Director

Elka Nir is the founder and CEO of E.LeadIN Ltd., a company that provides business, strategy, marketing, and investment consultancy services. She is also the CEO of Carmel Ltd., the economic corporation of Haifa University, Israel, where she leads commercial and business activities. Previously, Elka served as Managing Director, Giza Venture Capital; COO & Director of Development, Biosense Webster (Israel), Johnson & Johnson; and VP, R&D, and VP Marketing at General Electric Medical Systems (GE), Israel. She was a non-executive external director of BATM Advanced Communications Ltd. (LSE), a board member of Israel Advanced Technology Industries (IATI) and a director and investment committee member at Van Leer Technology Ventures. Elka brings extensive marketing, investment, business development, and operations experience.

Stephen Philip Haslett – Independent Director

Stephen Philip Haslett is the managing director (Asia Pacific) of Memjet Incorporated, developers of next-generation printer technology for office and commercial applications. In addition, he provides consultancy services in business development and commercialization through Silver Fox Pte Ltd., a company he founded. He has more than 30 years of experience in the IT business, and has held executive positions at Hewlett Packard, Dell Computer, and various technology start-ups where he assisted in the commercialization and globalization of their technologies. A professor of entrepreneurship at INSEAD, Haslett taught postgraduate and executive courses on entrepreneurship, private equity, venture capital, and computer-based business stimulations.

Professor Hang Chang Chieh – Independent Director

Professor Hang Chang Chieh is the head, Division of Engineering & Technology Management, of the National University of Singapore (NUS), a position he has held since 2007. He served in a number of positions at NUS, including vice-dean of engineering, head of the department of electrical engineering and deputy vice-chancellor (research and business ventures). Between 2001 and 2003, Professor Hang was seconded to the Agency for Science, Technology and Research (A*STAR) and acted as A*STAR’s executive deputy chairman. Professor Hang was founding deputy chairman of Singapore’s National Science and Technology Board, founding chairman of the Intellectual Property Office of Singapore, a member of the board of trustees of the Singapore Institute of Technology, and has served as a director in public companies.

Exits and Awards

We took two companies public and exited six companies.
Read more

IR Contact Details

Judith Kleinman
Director, Investor Relations and Corporate Communications
The Trendlines Group
+972.72.260.7000
judith@trendlines.com

 


Romil Singh / Reyna Mei
Financial PR Pte Ltd
+65 6438 2990
investors@trendlines.com

Copyright 2017 The Trendlines Group

Delivered by Investis – link to website (opens in a new window)